Loss of DOCK2 potentiates Inflammatory Bowel Disease–associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expression
Open Access
- 7 September 2024
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 43 (42) , 3094-3107
Abstract
Inflammatory Bowel Disease-associated colorectal cancer (IBD-CRC) is a known and serious complication of Inflammatory Bowel Disease (IBD) affecting the colon. However, relatively little is known about the pathogenesis of IBD-associated colorectal cancer in comparison with its sporadic cancer counterpart. Here, we investigated the function of Dock2, a gene mutated in ~10% of IBD-associated colorectal cancers that encodes a guanine nucleotide exchange factor (GEF). Using a genetically engineered mouse model of IBD-CRC, we found that whole body loss of Dock2 increases tumourigenesis via immune dysregulation. Dock2-deficient tumours displayed increased levels of IFNγ-associated genes, including the tryptophan metabolising, immune modulatory enzyme, IDO1, when compared to Dock2-proficient tumours. This phenotype was driven by increased IFNγ-production in T cell populations, which infiltrated Dock2-deficient tumours, promoting IDO1 expression in tumour epithelial cells. We show that IDO1 inhibition delays tumourigenesis in Dock2 knockout mice, and we confirm that this pathway is conserved across species as IDO1 expression is elevated in human IBD-CRC and in sporadic CRC cases with mutated DOCK2. Together, these data demonstrate a previously unidentified tumour suppressive role of DOCK2 that limits IFNγ-induced IDO1 expression and cancer progression, opening potential new avenues for therapeutic intervention.Keywords
This publication has 46 references indexed in Scilit:
- MetaboAnalyst: a web server for metabolomic data analysis and interpretationNucleic Acids Research, 2009
- Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomicsJournal of Lipid Research, 2008
- Protective Immunosurveillance and Therapeutic Antitumor Activity of γδ T Cells Demonstrated in a Mouse Model of Prostate CancerThe Journal of Immunology, 2008
- Tissue‐specific and inducible Cre‐mediated recombination in the gut epitheliumGenesis, 2004
- DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1Blood, 2003
- γδ T Cells Provide an Early Source of Interferon γ in Tumor ImmunityJournal of Experimental Medicine, 2003
- Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell ProliferationThe Journal of Immunology, 2000
- Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1999
- Inhibition of T Cell Proliferation by Macrophage Tryptophan CatabolismJournal of Experimental Medicine, 1999
- Rapid Colorectal Adenoma Formation Initiated by Conditional Targeting of the Apc GeneScience, 1997